相关实验视频
Updated: Jun 12, 2025
16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.2K
[可植入心室辅助装置的现状]
Yangsin Lee1, Masahiko Ando, Minoru Ono
1Department of Cardiovascular Surgery, The University of Tokyo, Tokyo, Japan.
Kyobu geka. The Japanese journal of thoracic surgery
|June 10, 2025
概括
植入式心室辅助器件 (iVAD) 在日本越来越多地用于桥梁到移植和目的地治疗. 管理像驱动线感染这样的并发症对于改善长期IVAD患者的治疗结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 手术技术 手术技术
背景情况:
- 植入式心室辅助器件 (iVADs) 于2011年在日本首次被批准用于桥梁至移植 (BTT).
- iVAD植入物的数量大幅增加,特别是在2021年获得目的地治疗 (DT) 批准后.
- 越来越多地使用IVAD,包括DT,由于缺乏捐赠者,影响了心脏移植等待名单.
研究的目的:
- 审查日本iVAD治疗的最新情况.
- 专注于管理BTT和DT患者的设备相关并发症.
- 为了突出关键的并发症,如驱动线感染,右心室衰竭和大动脉吐.
主要方法:
- 这是一篇综述文章,总结了现有的数据和文献.
- 重点是日本的IVAD相关的临床结果和并发症.
- 对BTT和DT指示的IVAD植入趋势的分析.
主要成果:
- 自2011年以来,已经进行了超过1458次BTT iVAD植入.
- iVAD植入率正在迅速增加,特别是在DT批准后.
- 设备相关的并发症,包括传动线感染,RV故障和AR,需要谨慎管理长期支持.
结论:
- 有效管理与设备相关的并发症对于改善IVAD患者的治疗结果至关重要.
- 长期的IVAD支持需要策略来减轻感染和心脏功能障碍等风险.
- 鉴于在日本越来越多地使用IVAD和供体限制,解决并发症至关重要.
更多相关视频
16:40A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
26.2K
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.2K
相关概念视频
01:29Cardiomyopathy V: Interprofessional Care
2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
01:30Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1